243 related articles for article (PubMed ID: 36578296)
1. Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant.
Khazaie H; Sadeghi M; Khazaie S; Hirshkowitz M; Sharafkhaneh A
Front Psychiatry; 2022; 13():1070522. PubMed ID: 36578296
[TBL] [Abstract][Full Text] [Related]
2. Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis.
Xue T; Wu X; Li J; Chen S; Wang Z; Tan X; Wang Z; Zhang J
Front Pharmacol; 2023; 14():1175372. PubMed ID: 37261282
[No Abstract] [Full Text] [Related]
3. Evidence-based insomnia treatment strategy using novel orexin antagonists: A review.
Kishi T; Nishida M; Koebis M; Taninaga T; Muramoto K; Kubota N; Moline M; Sakuma K; Okuya M; Nomura I; Iwata N
Neuropsychopharmacol Rep; 2021 Dec; 41(4):450-458. PubMed ID: 34553844
[TBL] [Abstract][Full Text] [Related]
4. Lemborexant, an orexin receptor antagonist sedative-hypnotic: Is it useful for insomnia in psychiatric disorders?
Keks NA; Hope J
Australas Psychiatry; 2022 Aug; 30(4):530-532. PubMed ID: 35491942
[TBL] [Abstract][Full Text] [Related]
5. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis.
Xue T; Wu X; Chen S; Yang Y; Yan Z; Song Z; Zhang W; Zhang J; Chen Z; Wang Z
Sleep Med Rev; 2022 Feb; 61():101573. PubMed ID: 34902823
[TBL] [Abstract][Full Text] [Related]
7. Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Kishi T; Matsunaga S; Iwata N
PLoS One; 2015; 10(8):e0136910. PubMed ID: 26317363
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis.
McElroy H; O'Leary B; Adena M; Campbell R; Monfared AAT; Meier G
J Manag Care Spec Pharm; 2021 Sep; 27(9):1296-1308. PubMed ID: 34121443
[No Abstract] [Full Text] [Related]
9. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials.
Moline M; Zammit G; Yardley J; Pinner K; Kumar D; Perdomo C; Cheng JY
Postgrad Med; 2021 Jan; 133(1):71-81. PubMed ID: 33119423
[TBL] [Abstract][Full Text] [Related]
10. Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis.
Kishi T; Nomura I; Matsuda Y; Sakuma K; Okuya M; Ikuta T; Iwata N
J Psychiatr Res; 2020 Sep; 128():68-74. PubMed ID: 32531478
[TBL] [Abstract][Full Text] [Related]
11. Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis.
Na HJ; Jeon N; Staatz CE; Han N; Baek IH
Sleep; 2024 Feb; 47(2):. PubMed ID: 37950346
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women.
Rahman SA; Nathan MD; Wiley A; Crawford S; Cohn AY; Harder JA; Grant LK; Erickson A; Srivastava A; McCormick K; Bertisch SM; Winkelman JW; Joffe H
Sleep; 2022 Mar; 45(3):. PubMed ID: 35022783
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of suvorexant and lemborexant for insomnia treatment.
Hayashi T; Yamanashi T; Iwata M
PCN Rep; 2023 Mar; 2(1):e85. PubMed ID: 38868407
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
15. Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.
Chepke C; Jain R; Rosenberg R; Moline M; Yardley J; Pinner K; Kumar D; Perdomo C; Filippov G; Atkins N; Malhotra M
Postgrad Med; 2022 Apr; 134(3):316-325. PubMed ID: 35254948
[TBL] [Abstract][Full Text] [Related]
16. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2014 Dec; 68(12):1429-41. PubMed ID: 25231363
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.
Arnold V; Ancoli-Israel S; Dang-Vu TT; Mishima K; Pinner K; Malhotra M; Moline M
Neurol Ther; 2024 May; ():. PubMed ID: 38748321
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents.
Ikeda S; Azuma MK; Fujimoto K; Shibahara H; Inoue S; Moline M; Ishii M; Mishima K
Psychol Med; 2022 Oct; 52(13):2822-2834. PubMed ID: 35506334
[TBL] [Abstract][Full Text] [Related]
19. Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder.
Waters K
Ann Pharmacother; 2022 Feb; 56(2):213-221. PubMed ID: 34078141
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.
Michelson D; Snyder E; Paradis E; Chengan-Liu M; Snavely DB; Hutzelmann J; Walsh JK; Krystal AD; Benca RM; Cohn M; Lines C; Roth T; Herring WJ
Lancet Neurol; 2014 May; 13(5):461-71. PubMed ID: 24680372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
